Longtime Valeant Investor Sequoia Fund Exits After Losses

Updated on
  • Holding ‘badly penalized our results’ in 2016, committee says
  • Battered drug stock was biggest position at start of the year

Ruane, Cunniff & Goldfarb, manager of the Sequoia Fund and once the largest shareholder in Valeant Pharmaceuticals International Inc., said the $4.8 billion mutual fund exited that investment last month after losses.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.